Managing maternal hemorrhage with uterine balloon tamponade techniques

Postpartum hemorrhage remains one of the most unpredictable obstetric emergencies, and although most Australian women give birth in well-resourced hospitals, geography still shapes outcomes. From the sprawling cattle country of western Queensland to the small maternity units of the Top End, distance and workforce limitations mean clinicians often need to stabilise a bleeding mother long before retrieval or transfer can occur. Uterine balloon tamponade has become a cornerstone of that stabilisation, sitting between medical therapy and definitive surgery in modern postpartum hemorrhage protocols.

The technique is straightforward in principle: a balloon is placed inside the uterine cavity and inflated with fluid, applying hydrostatic pressure against the bleeding placental bed and encouraging the myometrium to contract around it. In practice, though, device choice, insertion technique, and timing vary considerably, and the evidence base has matured alongside newer purpose-built devices. Australian maternity teams are increasingly expected to be competent with at least one balloon system, and many rural GP-obstetricians carry improvised kits as a backup.

This overview walks through how uterine balloon tamponade fits into contemporary hemorrhage management, the devices commonly encountered in Australian hospitals, the practical steps of insertion and monitoring, and the particular challenges faced in remote and Indigenous maternity care. It also looks at training frameworks such as PROMPT and the role of professional bodies in keeping skills current.

Understanding uterine balloon tamponade in postpartum hemorrhage

Postpartum hemorrhage is traditionally defined as blood loss of 500 mL or more following birth, with severe postpartum hemorrhage usually reserved for losses above 1000 mL or any bleeding that causes haemodynamic compromise. The leading cause is uterine atony, accounting for around 70 percent of cases, followed by retained tissue, trauma, and coagulopathy. When first-line measures, including uterine massage, emptying the bladder, and uterotonics such as oxytocin, ergometrine, misoprostol, or carboprost, fail to control bleeding, clinicians move quickly to second-line options.

Uterine balloon tamponade occupies a critical middle step in this algorithm. The balloon conforms to the shape of the uterine cavity, and the pressure it generates mechanically compresses the spiral arterioles at the placental site. At the same time, the stretching of the myometrium is thought to provoke further contractile activity, although the exact mechanism is still debated. Compared with surgical approaches such as the B-Lynch suture, bilateral uterine artery ligation, or peripartum hysterectomy, balloon tamponade is faster, requires no specialised surgical skill, and is reversible. It therefore buys time, both for the mother's physiology to stabilise and for transfer to a theatre or tertiary centre if needed.

Guidelines issued through the Royal Australian and New Zealand College of Obstetricians and Gynaecologists recommend that uterine balloon tamponade be available in every birthing unit that manages vaginal births. The college frames the device as part of a structured response rather than a stand-alone intervention, meaning it should be deployed alongside ongoing uterotonic infusion, accurate fluid resuscitation, and activation of massive transfusion protocols where indicated.

Common devices used in Australian practice

Several balloon systems are used across Australian maternity units, and familiarity often depends on what a particular health service has standardised. The Bakri balloon, designed specifically for postpartum hemorrhage, is the most widely distributed and comes with a purpose-built silicone shaft and a drainage port that allows ongoing assessment of blood loss above the balloon. It is typically filled with 300 to 500 mL of warm saline.

Improvised devices remain popular where cost or supply chains are tight. A Foley catheter, usually a large 24 French gauge, can be inserted through the cervix and the bulb inflated, though the small capacity limits its haemostatic effect in atonic uteri. The condom catheter, where a surgical glove or condom is tied over a Foley catheter and inflated, has been championed in low-resource settings and has found a niche in some remote Australian services for its low cost and reasonable efficacy. Newer purpose-built systems such as the Ellavi balloon offer a free-flow design that conforms to uterine shape and is gaining traction in larger tertiary centres.

Device Typical fill volume Indicative cost (AUD) Common Australian setting Key features
Bakri balloon 300–500 mL 250–400 Tertiary and regional hospitals Purpose-built, drainage port, silicone shaft
Foley catheter 60–80 mL 5–15 Small rural units, retrieval kits Improvised, very low cost, limited volume
Condom catheter 250–500 mL 5–20 Remote clinics, low-resource contexts Cheap, customisable, evidence in LMIC literature
Ellavi balloon Up to 750 mL 200–350 Larger metropolitan services Free-flow hydrostatic, conforms to cavity
Rusch urological balloon 30–60 mL 30–60 Rare in obstetrics Off-label use, limited data

Device selection is rarely a question of clinical superiority alone. Many smaller Western Australian and Northern Territory services keep both a commercial device and an improvised condom catheter on their postpartum hemorrhage trolley, allowing the on-call clinician to choose based on availability and the clinical picture. Larger tertiary centres tend to standardise on the Bakri or Ellavi to simplify training, while retaining an improvised option for rare cases where the primary device is unavailable.

Insertion technique and clinical monitoring

Insertion begins with a rapid assessment of the mother. Two large-bore cannulas, bloods sent for full blood count, coagulation screen, and group and crossmatch, and continuous monitoring of pulse, blood pressure, and oxygen saturation are all part of standard preparation. The bladder is emptied, and a vaginal examination confirms that retained products, lacerations, or expanding haematomas are not the primary source of bleeding.

The balloon is then inserted through the cervix, either directly or using sponge forceps to guide it past the internal os. For the Bakri device, the shaft sits in the cervical canal and the balloon sits in the uterine cavity; traction on the shaft or vaginal packing keeps the balloon apposed to the lower uterine segment. Warm saline is instilled in 50 mL increments while an assistant monitors the mother's response and the amount of blood escaping through the drainage port or vaginally.

Concurrent management does not stop at insertion. An oxytocin infusion is usually continued, and a second uterotonic such as misoprostol or carboprost is added if not already in place. The mother remains under close observation, with observations recorded every 15 minutes initially. The balloon is generally left in place for 12 to 24 hours, after which the saline is released gradually and the device removed, with uterotonics continued for several hours afterward to prevent rebound bleeding.

Challenges in rural and remote Australian settings

Distance defines much of Australian maternity care. A woman birthing in a remote Western Australian community may be hundreds of kilometres from the nearest caesarean section capability, and the Royal Flying Doctor Service or state-based retrieval teams need several hours to mobilise. In this window, balloon tamponade can be the difference between a stabilised transfer and a catastrophic collapse on the floor of a small district hospital.

Indigenous Australian women experience higher rates of postpartum hemorrhage and severe morbidity, reflecting a combination of higher parity, anaemia, and reduced access to continuity of care. Culturally safe models such as birthing on country programs in the Northern Territory and parts of South Australia are changing this picture, but balloon tamponade remains an essential skill for clinicians working in these programs. Condom catheters, given their low cost and ease of assembly, are sometimes used as a first-line tamponade in community settings where commercial devices are not stocked.

Telehealth support has also matured. Senior obstetricians can now guide a remote clinician through balloon insertion over a video link, while retrieval teams coordinate blood product delivery from regional hubs. The wider perinatal community, including bodies such as the Federation of Asian and Oceania Perinatal Societies, has long emphasised knowledge sharing across geographically dispersed regions, and topics such as these feature regularly in their educational programs.

Evidence, outcomes, and comparative effectiveness

Published success rates for uterine balloon tamponade in controlling atonic postpartum hemorrhage sit broadly between 80 and 95 percent, with most large series reporting figures around 85 to 90 percent when the device is used as part of a structured response. A 2020 systematic review and meta-analysis found that balloon tamponade reduced the need for surgical intervention compared with continuing medical therapy alone, without increasing the risk of infection or uterine damage.

Comparative effectiveness data is less clear-cut. Most trials compare balloon tamponade with no balloon rather than head-to-head between devices, leaving clinicians to choose based on availability and experience. Failure is more likely when bleeding is due to placenta accreta, when the uterus is grossly distorted by fibroids, or when tamponade is deployed late after substantial blood loss has already occurred. Earlier use, ideally within the first hour of failed medical therapy, is consistently associated with better outcomes.

For Australian audiences, local data is reassuring. State perinatal outcome reports from Victoria, New South Wales, and Queensland show sustained low maternal mortality rates from hemorrhage over the past two decades, attributed to a combination of well-organised retrieval services, mature massive transfusion protocols, and clinician training. Still, case reviews continue to identify delays in escalation as a recurring theme, reinforcing the value of clear, locally agreed pathways that include balloon tamponade as an explicit step.

Training, protocols, and system integration

Skill with uterine balloon tamponade is no longer optional in Australian maternity care. The PROMPT course, originally developed in the United Kingdom and widely adopted across Australian hospitals, includes a dedicated postpartum hemorrhage module that covers balloon insertion on a pelvic trainer. Many services now run annual multidisciplinary drills, pulling together midwives, obstetricians, anaesthetists, and blood bank staff to rehearse the entire response from first uterotonic through to theatre handover.

Hospital protocols matter as much as individual skill. A well-designed pathway specifies who is authorised to insert a balloon, what fluid is used, how much is instilled, and when the on-call consultant is notified. Some smaller services maintain pre-packed tamponade kits alongside their postpartum hemorrhage trolley, so that equipment is immediately to hand rather than gathered from storerooms in the heat of an emergency. Audit of these pathways, including time-to-tamponade and balloon success rates, is increasingly part of accreditation cycles.

Education also extends well beyond the clinical workforce. Programs that include Aboriginal health workers, retrieval nurses, and even non-clinical staff in awareness raising help ensure that the broader team recognises postpartum hemorrhage early and triggers the response chain. International knowledge exchange complements local training and helps Australian clinicians learn from colleagues managing similar challenges across Asia and the Pacific, with resources hosted on the FAOPS 2020 site offering one example of how regional societies share practical guidance.

If you are involved in maternity care, take time this year to review your local postpartum hemorrhage protocol and confirm that balloon tamponade is included as a clearly described step, with the equipment pre-packed and the team familiar with the chosen device. Practise the insertion on a pelvic trainer during your next in-service, and run a tabletop scenario that includes a delayed retrieval or transfer. For clinicians working in remote and Indigenous health settings, engage with retrieval services and telehealth colleagues to ensure that escalation pathways are understood by everyone who might need them. To explore related reading on maternal and neonatal care in resource-limited contexts, see this piece on neonatal tetanus prevention, which offers a useful companion perspective on how the same principles of early recognition and simple, effective intervention shape outcomes beyond the birthing suite.